Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

AstraZeneca's Ultomiris Meets Goal in Rare Kidney Disease Study
AstraZeneca's Ultomiris Meets Goal in Rare Kidney Disease Study

AstraZeneca AZN announced positive results from an interim analysis of the ongoing late-stage I CAN study, which evaluated its blockbuster rare disease drug Ultomiris (ravulizumab) for IgA

Spire to Sell Gas Storage Assets for $650M to I Squared Capital
Spire to Sell Gas Storage Assets for $650M to I Squared Capital

Spire Inc. SR recently announced that it has signed an agreement to divest its natural gas storage assets in Wyoming and Oklahoma (“Spire Storage”) to I Squared Capital for $650 million. The deal is

NVIDIA Sparks April Rally in 2 Quantum Stocks, 40%+ Upside Still Left: https://staticx-tuner.zacks.com/images/articles/main/87/146286.webp
NVIDIA Sparks April Rally in 2 Quantum Stocks, 40%+ Upside Still Left

The quantum computing sector continues to demonstrate extreme volatility in the back half of April due as much to macro forces as to technological progress. After a euphoric 2024-2025, when

Manhattan Associates (MANH) Surpasses Q1 Earnings and Revenue Estimates
Manhattan Associates (MANH) Surpasses Q1 Earnings and Revenue Estimates

Manhattan Associates (MANH) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.19 per share a year ago

Compared to Estimates, Manhattan Associates (MANH) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, Manhattan Associates (MANH) Q1 Earnings: A Look at Key Metrics

Manhattan Associates (MANH) reported $282.22 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 7.4%. EPS of $1.24 for the same period compares to $1.19 a

Here's Why AngloGold Ashanti (AU) Fell More Than Broader Market
Here's Why AngloGold Ashanti (AU) Fell More Than Broader Market

AngloGold Ashanti (AU) ended the recent trading session at $100.45, demonstrating a -5.67% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss

ASML: Dividende um 17% erhöht
ASML: Dividende um 17% erhöht

Rekordgewinne, massive Aktienrückkäufe und eine prall gefüllte Kasse treffen auf eine historisch hohe Bewertung.…

Der Beitrag ASML: Dividende um 17% erhöht erschien zuerst auf kapitalmarktexperten.d

5 Stocks to Buy as Retail Sales Soar Amid Ongoing Geopolitical Tensions
5 Stocks to Buy as Retail Sales Soar Amid Ongoing Geopolitical Tensions

Retail sales rose in March, surpassing expectations as the ongoing conflict with Iran saw gasoline prices climb more than 30% over the past month. Although oil prices played a major role in boosting

These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

How to Find Strong Aerospace Stocks Slated for Positive Earnings Surprises
How to Find Strong Aerospace Stocks Slated for Positive Earnings Surprises

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

If You Invested $1000 in Keysight a Decade Ago, This is How Much It'd Be Worth Now
If You Invested $1000 in Keysight a Decade Ago, This is How Much It'd Be Worth Now

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

Why American Express (AXP) is a Top Stock for the Long-Term
Why American Express (AXP) is a Top Stock for the Long-Term

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?
Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?

ADMA Biologics ADMA specializes in plasma-based therapies used to treat immune disorders and help prevent certain infections. Its flagship product, Asceniv, is an intravenous immunoglobulin (IVIG)

Alcoa Rebounds as Aluminum Tightens, But a Q1 Miss Tests the Rally
Alcoa Rebounds as Aluminum Tightens, But a Q1 Miss Tests the Rally

Global aluminum industry leader Alcoa (NYSE: AA) has served as the quintessential example of just how highly cyclical the basic materials sector can be.

So far this year, that cohort of stocks has

NIKE vs. adidas: Which Athletic Leader Deserves Investors' Attention?
NIKE vs. adidas: Which Athletic Leader Deserves Investors' Attention?

In the fiercely competitive global athletic apparel arena, few rivalries command as much attention as the ongoing contest between NIKE, Inc. NKE and adidas AG ADDYY. Both companies dominate shelves

AstroNova Soars 73% in a Year: Should You Buy the Stock?
AstroNova Soars 73% in a Year: Should You Buy the Stock?

AstroNova, Inc. ALOT shares have surged 72.8% in the past year compared with the industry’s 39.9% growth. The company has outperformed other industry players, including Mirion Technologies, Inc. MIR

Astera Labs: The Tollbooth for AI's Traffic Jam
Astera Labs: The Tollbooth for AI's Traffic Jam

A clear message was sent on Wall Street during the third week of April, signaling a new chapter in the artificial intelligence (AI) growth story. Astera Labs, Inc. (NASDAQ: ALAB) saw its stock

How to Find Strong Retail and Wholesale Stocks Slated for Positive Earnings Surprises
How to Find Strong Retail and Wholesale Stocks Slated for Positive Earnings Surprises

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among